The peripheral retina is the site of pathology in many ocular diseases and ultra-widefield (UWF) imaging is one of the new technologies available to ophthalmologists to manage some of these diseases. Currently, there are several imaging systems used in practice for the purpose of diagnostic, monitoring disease progression or response to therapy, and telemedicine. These include modalities for both adults and pediatric patients. The current systems are capable of producing wide-and UWF color fundus photographs, fluorescein and indocyanine green angiograms, and autofluorescence images. Using this technology, important clinical observations have been made in diseases such as diabetic retinopathy, uveitides, retinal vascular occlusions and tumors, intraocular tumors, retinopathy of prematurity, and age-related macular degeneration. Widefield imaging offers excellent postoperative documentation of retinal detachment surgery. New applications will soon be available to integrate this technology into large volume routine clinical practice.
The peripheral retina is the site of pathology in many ocular diseases such as diabetic retinopathy (DR), retinal vein occlusions, uveitis, vasculitis, choroidal and retinal masses, retinal tears, and detachments. While careful clinical examination of patient's peripheral retina with scleral indentation is of utmost importance in clinical decision making, there is a need for additional testing and an objective and reliable documentation of findings. Recent advances in the development of diagnostic imaging techniques have played an increasing role in better assessment of retinal periphery. Ultra-widefield (UWF) imaging is one of the new technologies available to retinal specialists. Current UWF imaging modalities can provide several options for posterior segment documentation and evaluation, including options for color images, red-free images, fluorescein and indocyanine green angiography, and fundus autofluorescence. [1, 2] Data from these modern imaging devices has truly changed the way ophthalmologists evaluate a patient picture and has led to more understanding of the role of the peripheral pathology in retinal diseases.
Evolution of Ultra-widefield Imaging Technology
The first reliable fundus camera, which allowed documentation of ocular fundus structures, was introduced by Carl Zeiss and J.W. Nordensen in 1926. This camera provided a 20° fundus image. Years later, Carl Zeiss Company expanded the field of view to 30° which became the standard for the traditional fundus camera. [3] This field of view obtained with traditional fundus cameras was adequate for imaging of the optic nerve and the posterior pole but provided a limited view of the retinal periphery. A protocol consisting of 7-standard 30° images was developed by the DR study for acquiring images of the retinal periphery in a systematic manner. The width of these composite images is approximately 75°. Photographs anterior to the equator may be obtained with this protocol, but they will not image structures in the far periphery. [4] This approach was extended to 9-standard fields protocol for the longitudinal studies of ocular complications of AIDS protocol to capture peripheral cytomegalovirus retinitis. Per specifications of the Fundus Photography Reading Center at the University of Wisconsin, retinal cameras approved for this procedure had 50° or 60° magnification settings. Such photography, however, may be limited by patient alignment problems, focusing irregularities, marginal corneal astigmatism, poor fixation, and light reflex artifacts [5] [ Fig. 1 ].
Since that time, several advances have been made to posterior segment imaging that permit visualization of the retinal periphery in a practical manner. Equator-plus camera is a specialized contact lens-based camera that was developed in 1975 by Pomerantzeff. A fiber optic illumination was separated from the camera to minimize lens reflections and obtain a 148° capture from the retina anterior to the equator. [6] The Retcam (Clarity Medical Systems, Pleasanton, California, USA) is a portable wide-angle camera system that was made commercially available in 1997. It is a contact-based, coaxial illumination system which obtains 130° field of view. [7] The system is particularly well-suited for imaging pediatric patients because it is portable and can be placed directly on patients unable to position themselves, such as neonates and infants [ Fig. 2a and b]. Specifically, this imaging modality has been well-studied in patients with retinopathy of prematurity. A major limitation in this technology, however, was its inability to image through lens opacities. [7] A major cause of artifact with any fundus imaging arises from the reflection of light from interfaces in the ocular media. Elimination of these reflections is achieved using confocal scanning laser ophthalmoscopy (SLO), which separates the illuminating and imaging beam within the eye. [5] Staurenghi et al. developed a combined contact and noncontact handheld lens system coupled with a SLO. The Staurenghi lens system. lens system obtained high-resolution images with a 150° field. However, this technique was cumbersome for the photographer [ Fig. 3 ]. [8] The Optos camera (Optos 200Tx, Dunfermline, UK) is a UWF imaging system, which produces a 200° view of the retina (about 82% of the surface area). The Optos technology utilizes a combined SLO with an ellipsoidal mirror to obtain images of the retinal periphery with one capture without the need for bright illumination lighting or a contact lens, and in some patients, pupillary dilation. The system provides the ability to capture red and green reflectance imaging, as well as fundus autofluorescence, and fluorescein/indocyanine green angiography [ Fig. 4a and b]. [9] Widefield imaging of the vitreous is now possible with the introduction of a biomicroscopic wide-angle retinal and vitreous observation system utilizing a 3 CCD video camera and a personal computer for image display by Lee and Chang [Figs. 5 and 6] . [10] Finally, optical coherence tomography (OCT) technology is making progress toward examining wider areas of the retina. The systems have now expanded from 30° to 55° (Heidelberg Spectralis system, Heidelberg Engineering, Germany). With moving of the scan toward the periphery, some areas can be visualized that were previously unreachable for OCT imaging. [11] Following is a review of wide-and UWF imaging application in some retinochoroidal diseases.
Diabetic Retinopathy
DR is a common complication of diabetes mellitus. It is one of the leading causes of blindness among adults and is estimated to be responsible for up to 17% of total blindness. [12, 13] Diabetic macular edema (DME) is a major cause of vision loss among diabetic patients. [14, 15] Ischemic changes and microvascular abnormalities in patients with DR have long been hypothesized to play a role in the development of DME. Ischemia stimulates the production of vascular endothelial growth factor (VEGF), which can lead to the breakdown of blood-retinal barriers, and development of macular edema. [16, 17] Accordingly, ischemic changes in the peripheral retina may induce macular edema. Several studies have demonstrated the association between peripheral retinal nonperfusion and the occurrence of neovascularization (NV) and DME. [18, 19] Conventional fluorescein angiography (FA) employs retinal photography that is able to view approximately 30° of the retina at 1 time, and hence missing the peripheral retina. With the advent of ultra-widefield fluorescein angiography (UWFA), it is now possible to view up to 200° of the retina in a single photograph measured from the ocular center. The ability to image the peripheral retina using UWFA provides a more comprehensive assessment of the extent of a retinal disease process, and may lead to detection of abnormalities that may alter treatment plans and give new insights into the pathogenesis of DME [ Fig. 7 ]. [1] New treatment modalities, like targeted retinal photocoagulation (TRP) may be effective for treatment of DME. It has been suggested that TRP may replace pan-retinal photocoagulation by directing therapy specifically at ischemic parts of the retina to precisely eliminate the source of VEGF, thus minimizing the sequelae of pan-retinal photocoagulation. [20] In addition, the combination of macular laser and anti-VEGF therapy, and TRP could prove to be an important treatment modality for DME. Despite the significant correlation of retinal ischemia with DME in patients with DR, Wessel et al. failed to detect an association between the amount of retinal ischemia and the degree of macular thickening. [21] In addition to the implication of UWFA in the management of DME, identification of specific areas of retinal nonperfusion with UWFA may allow targeted rather than pan photocoagulation in the treatment of NV. [22] If more laser is required it can at least be applied in a step-wise logical manner. This approach can minimize laser-induced side effects such as field loss and macular edema. [5] A recent study evaluated the efficacy of UWFA in the detection of diabetic pathology found that it was able to demonstrate retinal nonperfusion and NV in 10% of eyes that would have been missed by standard FA. [21] 
Uveitis
The diagnosis of posterior uveitis is challenging. Accurate diagnosis often requires careful clinical examination of the retinal periphery as posterior uveitis is associated with significant changes in this region. Management plans depend on the clinical appearance and angiographic pattern of the retinal lesions. Significant retinal findings are likely to be missed by conventional FAs but can be visualized using UWFA. [23] Kaines et al. noted that the high-resolution images obtained with UWF technology allowed clear identification of peripheral retinal lesions and greatly enhanced objective documentation of disease activity and progression. Similar to cases of DR, UWF imaging allowed clear visualization of the areas of NV and peripheral nonperfusion, leading to limited sector pan-retinal photocoagulation, and hence minimizing complications. [5] The added information provided by the UWF images may alter management decisions compared with the standard examination and conventional imaging. Such difference most likely is attributed to peripheral retinal imaging and angiographic findings are not easily identified without widefield imaging. [24] UWF fundus autofluorescence imaging was helpful in monitoring areas of old or new retinal inflammatory activity in patients with uveitis. It revealed areas of focal loss of autofluorescence that were in high concordance with visual field testing results, which showed deep scotomas. [25] Similarly, UWF imaging may allow earlier detection of disease activity in patients with noninfectious vasculitis, which may lead to earlier treatment and perhaps better patient outcomes [ Fig. 8 ]. [26] Leakage from retinal vessels may be seen before there are obvious ophthalmoscopic signs of vasculitis. In some cases of retinal vasculitis, the vessels anterior to the equator may be involved and cause peripheral leakage, ischemia, and NV, which are difficult to detect clinically. Accordingly, visualization of the peripheral retina could be essential to the diagnosis, monitoring, and treatment of retinal vasculitis. [26] Mesquida et al. assessed the role of UWF retinal imaging in the diagnosis and management of retinal vasculitis associated with Behçet disease. [27] They found that UWF retinal imaging had allowed clear documentation of peripheral retinal lesions and greatly simplified longitudinal comparisons for disease activity and progression. Peripheral vein sheathing and retinal infiltrates that denote disease activity were clearly detected with UWF pseudocolor imaging in their study. They also found that UWFA seems to evaluate precisely the early and subclinical retinal involvement. UWFA was a very helpful tool in their patients for determining whether the vasculitis had an occlusive nature and for quantifying the true extent of the capillary nonperfusion. Areas of retinal ischemia and NV were easily identified in their series, aiding targeted laser photocoagulation. The findings of the study also suggested that active retinal vasculitis in patients with Behçet disease may induce retinal epithelium alterations in the retinal periphery. These abnormalities were visible with UWF fundus autofluorescence as multiple hyper fluorescent spots in the retinal periphery. [27] 
Retinal Vein Occlusion
Retinovascular occlusive disease is a very common indication for wide and UWF imaging [ Fig. 9 ]. Prasad et al. evaluated the use of UWFA to study the peripheral angiographic features of branch retinal vein occlusions (BRVO) and hemicentral retinal vein occlusions (HRVO). They found that UWFA may provide visualization of peripheral retinal pathology in BRVO and HRVO patients, which may be useful in their evaluation and treatment. They suggested that areas of untreated retinal nonperfusion may be the source of production of biochemical mediators that promote NV and macular edema. Accordingly, they concluded that UWFA may be a powerful tool to identify therapeutic target areas for photocoagulation, allowing for efficient treatment of ischemic retina, and potentially minimizing collateral destruction of adjacent viable perfused retina. [28] A study by Tsui et al. [29] has identified an ischemic index in retinovascular occlusions which describe a ratio of nonperfused retina over the whole retinal area measured manually from ultra-wide angle FAs.
Age-related Macular Degeneration
Age-related macular degeneration (AMD) is the leading cause of irreversible central vision loss among the elderly population and seriously compromises their quality of life. The vast majority of AMD-related vision loss results from exudative AMD, characterized by invasion of blood vessels into the subretinal space. [30, 31] AMD is a multifactorial disease. The pathogenesis of AMD is complex with genetic, degenerative, and environmental predisposing factors. Hypoxia and ischemia are thought to play a role in the progression of AMD to neovascular AMD. [32] It is possible that peripheral retinal ischemia may contribute significantly to an abnormal angiogenic drive, mediated primarily by VEGF. [33] In a recent study by Madhusudhan and Beare, peripheral leakage, as indicated on UWFA, was noted to be associated with active neovascular AMD in a proportion of patients compared to the fellow eyes without active neovascular AMD. However, the authors found that the association between peripheral retinal nonperfusion and neovascular AMD was not significant. [32] Further studies to evaluate the significance of the abnormal findings in the peripheral retina in patients with AMD are required to improve our understanding of the pathogenesis of the disease. In a prospective study that was conducted to characterize peripheral fundus autofluorescence abnormalities in patients with AMD, significant risk factors for peripheral autofluorescence abnormalities were neovascular AMD compared with nonneovascular AMD and normal eyes, older age, and female sex. These findings may contribute to more understanding of the pathogenesis and the prognosis of the disease. [33] Retinopathy of Prematurity UWFA images showed clear views of the different stages of ROP features at the posterior pole and peripheral retina. With the help of UWFA images, regression of ROP features was identified, following laser and intravitreal bevacizumab treatment. In addition, it was made possible that the "skip areas" that were missed by initial laser treatment could be identified in the peripheral retina and managed accordingly. [34] 
Choroidal Melanoma
Choroidal melanoma is the most common primary malignant ocular neoplasm in adults. It metastasizes into several organs and metastasis may occur before the primary tumor is diagnosed. [35] Therefore, early detection is essential. Clinical differentiation of malignant melanoma from benign choroidal nevus may be difficult. Shields et al. identified five predictive clinical features in order to help clinicians better differentiate small malignant melanoma from a benign choroidal nevus. These included: Tumor thickness > 2 mm, presence of subretinal fluid, clinical symptoms, orange pigment overlying the surface of the tumor, and tumor margins touching or being located within 3 mm of the optic disc. [36] Reznicek et al. obtained images using UWF technology for more accurate evaluation of the criteria established by Shields et al. such as evaluation of location of the lesion in relation to the optic nerve, subretinal fluid, and maximal horizontal and vertical diameter. In addition they found, that the mean fundus autofluorescence intensity of melanomas was significantly lower than the autofluorescence of choroidal nevi and this combined with clinical criteria, and UWF images may help in the differential diagnosis. [37] In addition, measurements of the size of pigmented choroidal lesions using UWF imaging were found to be reasonably correlated with ultrasound measurements. [38] 
Coats' Disease
Coats' disease is an idiopathic, retinal vascular abnormality of young males characterized by telangiectatic retinal vessels with aneurysms [ Fig. 10 ]. Abnormal permeability of these vessels leads to exudative retinal detachment and subretinal lipid deposits. Often, subfoveal exudation leading to permanent severe vision loss occurs prior to the presentation. The severe forms of the disease often involve neovascular glaucoma and phthisis bulbi. [39, 40] UWF fundus photography and angiography can be used successfully as an outpatient procedure in the pediatric patient population without the necessity of examination under anesthesia and can aid the physician in the documentation and evaluation of Coat's disease. [41] Von Hippel-Lindau Disease Von Hippel-Lindau disease (VHL) is an autosomal dominant inherited systemic cancer syndrome that gives rise to cystic and highly vascularized tumors in many organs, including the eye. [42] Patients with VHL are at increased risk of developing central nervous system and retinal hemangioblastomas, clear cell renal carcinoma, pheochromocytomas, neuroendocrine tumors and cysts of the pancreas, endolymphatic sac tumors, papillary cystadenomas of the epididymis, and broad ligament. [43] Retinal hemangioblastomas, present in up to 85% of individuals with VHL, are the most common lesion of VHL disease. [44] Retinal Detachment UWF autofluorescence imaging may reveal abnormalities in the rhegmatogenous retinal detachment that allow excellent demarcation of the extent of the retinal detachment and assist in the preoperative characterization of the detachment and may help in postoperative counseling [ Fig. 11 ]. [45] It may also be useful in documenting multiple foci of exudative detachment and response to treatment as well as for patient education. 
Future Directions
Imaging of the peripheral retina has significantly improved over the past years. Widefield technology has become important clinically with regards to early diagnosis, effective treatment, and monitoring of most sight-threatening retinal diseases. In the future, widefield imaging may have significant utility as a research tool particularly for evaluating new treatment approaches. It is likely that with additional time, the full utility of widefield imaging will be revealed, and this may enable more rapid progress in understanding retinal pathology. Advancements in telemedicine methods and the development of portable fundus cameras have increased the accessibility of retinal imaging, but most of these approaches rely on separate computers for viewing and transmission of fundus images. Recently, a novel portable handheld smartphone-based retinal camera capable of capturing high-quality, widefield fundus images was developed. The use of the mobile phone platform creates a fully embedded system capable of acquisition, storage, and analysis of fundus images that can be directly transmitted from the phone via wireless telecommunication system for remote evaluation. [46] Telemedicine programs have shown that nonphysician operators can be trained to obtain images for remote expert interpretations. [47] Photographic documentation can also be a valuable asset for medico-legal and educational purposes. [48] A significant amount of work is going on to validate and expand the utilization of UWF imaging. Not so far in the future, we believe that UWF imaging technology will be indispensable for the routine daily retina practice.
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